[Quality assurance in interventional cardiology].
Quality assurance in clinical studies aiming at approval of pharmaceutical products is submitted to strict rules, controls and auditing regulations. Comparative instruments to ensure quality in diagnostic and therapeutic procedures are not available in interventional cardiology, likewise in other fields of cardiovascular medicine. Quality assurance simply consists of "quality registers" with basic data not externally controlled. Based on the experiences of clinical studies and their long history of standardization it is assumed that these data may be severely flawed thus being inappropriate to set standards for diagnostic and therapeutic strategies. The precondition for quality assurance are quality data. In invasive coronary angiography and intervention medical indications, the decision making process interventional versus surgical revascularization, technical performance and after - care are essential aspects affecting quality of diagnostics and therapy. Quality data are externally controlled data. To collect quality data an appropriate infrastructure is a necessary precondition which is not existent. For an appropriate infrastructure investments have to be done both to build up as well as to sustain the necessary preconditions. As long as there are no infrastructure and no investments there will be no "quality data". There exist simply registers of data which are not proved to be a basis for significant assurance and enhancement in quality in interventional coronary cardiology.
Gülker
H
H
Herzzentrum, Universitätsklinikum Wuppertal. wuppertal-helios-kliniken.de
D017130:Angioplasty / Q000592:standards; D015906:Angioplasty, Balloon, Coronary / Q000592:standards*; D002309:Cardiology / Q000592:standards*; D017023:Coronary Angiography / Q000592:standards*; D003657:Decision Making; D005858:Germany; D006801:Humans; D009204:Myocardial Revascularization / Q000592:standards; D011785:Quality Assurance, Health Care; D012042:Registries